Swixx Biopharma

company

About

Swixx Biopharma fully represents biopharma companies in the CEE.

  • 501 - 1000

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€52M
Industries
Biopharma,Biotechnology,Life Science
Founded date
Dec 1, 2014
Number Of Employee
501 - 1000
Operating Status
Active

Swixx Biopharma fully represents biopharma companies in the CEE. It is designed to fully replace biopharma, OTC, and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit.

The company was founded in 2014 and is registered in Baar, Switzerland. It has 100%-owned affiliates in Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Kosovo, Latvia, Lithuania, North Macedonia, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, and Slovenia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€52M
Swixx Biopharma has raised a total of €52M in funding over 2 rounds. Their latest funding was raised on Mar 4, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 4, 2021 Debt Financing €52M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Swixx Biopharma is funded by 2 investors. Citi and UBS are the most recent investors.
Investor Name Lead Investor Funding Round
Citi Debt Financing
UBS Debt Financing